| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -46.64M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, TSHA returned +103.0% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +10.7% |
| 1 year | +103.0% |
| 5 years | -69.4% |
| All-time high | $26.54 (Dec 2020) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in TSHA would be worth today ›No. Taysha Gene Therapies, Inc. has not paid a dividend in the past 12 months.
Taysha Gene Therapies, Inc. stock trades on NASDAQ under the ticker symbol TSHA.
Taysha Gene Therapies, Inc. is part of the Healthcare sector.
Taysha Gene Therapies, Inc. has a market cap of 1.98B USD, based on the latest quote.
Taysha Gene Therapies, Inc. is expected to report earnings around Nov 4, 2026. That date is an estimate and has not been confirmed by the company.
